证券代码：600759 证券简称：洲际油气 公告编号：2025-018 号 次交易构成关联交易。 ?本次交易不构成重大资产重组。 ?本次关联交易经公司第十三届董事会第二十三次会议审议通过，无需提交 股东大会审议。 ?过去 12 个月内，公司与同一关联人（指 HUILING 女士及其控制的除本公 司之外的企业等交易主体）发生的除日常关联交易外的关联交易累计共 3 次，总 交易金额为人民币 4322.4 万元。 洲际油气股份有限公司关于公司控股子公司 向关联人借款暨关联交易的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ?洲际油气股份有限公司（以下简称"公司"或"洲际油气"）控股子公司 拟向实际控制人间接控股的子公司申请美元借款，借款总额为 3450 万美元。本 至本次交易为止，过去12个月内本公司与同一关联人（指HUILING) 女士及 其控制的除本公司之外的企业等交易主体）发生的除日常关联交易外的关联交易 累计共3次，总交易金额为人民币4322.4万元，占上市公司最近一期经审计净资 产0.5%。 ...

二○二五年五月二十日 圆通速递股份有限公司 会 议 资 料 中国·上海 目 录 关于《圆通速递股份有限公司第三期股票期权激励计划（草案）》及其摘要的议案 关于《圆通速递股份有限公司第三期股票期权激励计划实施考核管理办法》的议案 关于提请股东大会授权董事局办理公司第三期股票期权激励计划有关事项的议案25 圆通速递股份有限公司 会 议 须 知 根据中国证券监督管理委员会《上市公司股东大会规则》《公司章程》的有关规定， 为确保公司股东大会顺利召开，特制定会议须知如下，望出席股东大会的全体人员遵守 执行： 一、股东参加股东大会，应当认真履行其法定义务，不得侵犯其他股东权益； 二、股东大会期间，全体出席人员应以维护股东的合法利益、确保大会正常秩序和 议事效率为原则，认真履行法定职责； 三、出席大会的股东依法享有发言权、咨询权、表决权等各项权利，股东要求发言 时不得打断会议报告人的报告或其他股东的发言，股东要求发言时请先举手示意； 四、在会议集中审议议案过程中，股东按会议主持人指定的顺序发言和提问，建议 每位股东发言时间不超过 3 分钟，同一股东发言不超过两次，发言内容不超出本次会议 审议范围； 五、任何人不得扰乱大会的 ...

Overview - The company announced a supplementary notice regarding the payment of guarantee fees to related parties and the associated transactions [1] Transaction Details - The board of directors approved a proposal for the company to pay guarantee fees to related parties, which will be submitted for review at the 2024 annual general meeting [1] - The company’s wholly-owned subsidiary, Guizhou Daqin Tumor Hospital Co., Ltd., will receive a fixed asset loan from the Agricultural Development Bank of China, with guarantees provided by Guizhou Chitianhua Group and Zunyi Tiantong Plastic Co., Ltd. [1] - The guarantee fee payment is based on the assessed value of the collateral provided for the loan [2] Asset Evaluation - The assessed value of the collateral, which includes 66 properties and commercial spaces, is determined to be 200.8363 million yuan, reflecting a decrease of 22.23% from the previous bank assessment [2] - The decline in assessed value is attributed to reduced usable life of the assets and a sluggish real estate market [2] Adjusted Guarantee Fee Structure - The pricing basis for the guarantee fee will be adjusted according to the new assessed value [3] - The maximum estimated total guarantee fee is now capped at 34.6443 million yuan, calculated based on the new assessed value over a maximum period of 11.5 years [5] Future Implications - The adjustment in the assessed value of the collateral will lead to a reduction in the guarantee fees payable by the company [5] - The company aims to negotiate with the Agricultural Development Bank to release the guarantees by 2028, contingent on the hospital's operational performance [5]

Core Points - The company held its 2024 Annual General Meeting on May 19, 2025, chaired by Chairman Xi Huiming [1] - Various proposals were presented for shareholder approval, including the annual report, board and supervisory committee reports, financial settlement report, profit distribution plan, and financing plan for 2025 [2][3][4][6][9] Proposal Summaries - **Proposal 1: Annual Report** The company prepared the 2024 Annual Report and its summary, which has been approved by the audit committee, board, and supervisory committee [2][3] - **Proposal 2: Board Work Report** The board presented the 2024 Board Work Report, which includes independent directors' reports [3] - **Proposal 3: Supervisory Committee Work Report** The supervisory committee's work report for 2024 was presented for approval [4] - **Proposal 4: Financial Settlement Report** The company prepared the 2024 Financial Settlement Report, which has been approved by relevant committees [6] - **Proposal 5: Profit Distribution Plan** The company reported a net loss of 630.12 million yuan for 2024, leading to a proposal not to distribute profits for the year. The retained earnings will be used for operational needs and debt repayment [7][8] - **Proposal 6: Financing Plan for 2025** The company plans to apply for a credit limit of up to 4 billion yuan and a working capital loan of up to 1.5 billion yuan for 2025 [9] - **Proposal 7: Confirmation of Related Transactions** The company confirmed related transactions for 2024, ensuring they were necessary and conducted at fair market prices [10] - **Proposal 8: Expected Related Transactions for 2025** The company outlined expected related transactions for 2025, emphasizing fair pricing and normal business operations [19][20] - **Proposal 9: Audit Committee Report** The Audit Committee's performance report for 2024 was presented for approval [22] - **Proposal 10: Director and Supervisor Remuneration** The proposed remuneration for directors and supervisors for 2025 was detailed, with specific amounts for each position [24] - **Proposal 11: Authorization for Stock Issuance** The company seeks authorization to issue up to 300 million yuan in stock to specific investors, with conditions outlined for the issuance process [26][27][28]

证券代码：000859 证券简称：国风新材 公告编号：2025-032 安徽国风新材料股份有限公司 关于发行股份及支付现金购买资产并募集 配套资金暨关联交易申请文件 获得深圳证券交易所受理的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 安徽国风新材料股份有限公司（以下简称"上市公司"或"公司"） 拟通过发行股份及支付现金方式，向施克炜等 10 名交易对方购买其 合计持有的太湖金张科技股份有限公司（以下简称"金张科技"或"标 的公司"）46,263,796 股股份（占金张科技库存股注销后总股本比 例为 58.33%），并向包括合肥市产业投资控股（集团）有限公司（以 下简称"产投集团"）在内的不超过 35 名符合条件的特定对象发行 股份募集配套资金（以下简称"本次交易"）。 公司于 2025 年 5 月 8 日收到深圳证券交易所（以下简称"深交 所"）出具的《关于受理安徽国风新材料股份有限公司发行股份购买 资产并募集配套资金申请文件的通知》（深证上审〔2025〕63 号）。 深交所根据相关规定对公司报送的发行股份及支付现金购买资产并 募集配套资金暨关联交易 ...

Core Viewpoint - The 2024 Annual General Meeting of He Feng Food Co., Ltd. will discuss various proposals, including the execution of related party transactions and the company's financial performance, highlighting a significant profit increase and strategic governance improvements [1][4][13]. Group 1: Company Performance - The company achieved a net profit of 342 million yuan in 2024, a year-on-year increase of 174.93%, marking a turnaround from a loss [4][13]. - The total revenue for 2024 was 32.55 billion yuan, a decrease of 9.52% compared to the previous year [13][14]. - The company's total assets at the end of the reporting period were 14.88 billion yuan, a slight decrease of 0.37% from the previous year [13][14]. Group 2: Governance and Management - The board of directors has been recognized for its effective governance, receiving an A-level rating for information disclosure for seven consecutive years [5]. - The company completed a board restructuring and appointed a new management team, enhancing governance and operational efficiency [5][9]. - The company executed two rounds of share repurchase plans, spending 287 million yuan to buy back 39.99 million shares, reflecting management's confidence in the company's value [5][9]. Group 3: Related Party Transactions - The company reported that its related party transactions in 2024 were necessary for normal operations, with pricing based on market rates, ensuring compliance with legal and regulatory standards [17][18]. - The total expected amount for related party transactions in 2025 is projected to be 159.4 million yuan, with various categories of transactions detailed [17][18]. Group 4: Future Outlook - The company aims to strengthen its feed business, enhance the meat poultry industry, and improve cash flow and risk management in the coming years [9][12].

Group 1 - The company will hold its 2024 Annual General Meeting on May 20, 2025, at 14:30, with both on-site and online voting options available [1][2] - The meeting agenda includes the reading of the meeting notice, discussion of proposals, shareholder speeches, and voting procedures [2][3] - There are 9 proposals to be voted on, requiring more than half of the voting rights held by attending shareholders for approval [4] Group 2 - The company reported a net profit of 30.48 million yuan for 2024, marking a turnaround from previous losses, with total assets of 758.88 million yuan and net assets of 325.71 million yuan [5] - The board of directors has organized two shareholder meetings during the reporting period, addressing various reports and proposals [6][7] - The board held 9 meetings, discussing topics such as executive compensation and the election of board members [8][9] Group 3 - The supervisory board held 6 meetings, reviewing the company's financial reports and ensuring compliance with legal regulations [26][31] - The supervisory board confirmed that the company operates in accordance with laws and regulations, with no violations reported [32] - The company has established a sound internal control system, with audits confirming compliance and effectiveness [35] Group 4 - The company plans to distribute a cash dividend of 0.118 yuan per share for the 2024 fiscal year, totaling approximately 9.14 million yuan, which is 30% of the net profit [40] - The company has outlined its expected related party transactions for 2024 and 2025, with a total estimated amount of 74.5 million yuan for various services [42][43] - The company has implemented measures to manage insider information and ensure compliance with disclosure regulations [22][36]

Core Viewpoint - The company plans to provide a mutual guarantee of up to 270 million RMB for Zhejiang Bozhong Zhizhi Technology Innovation Group Co., Ltd. and its wholly-owned subsidiary, Zhejiang Jilin Import and Export Co., Ltd. for the year 2025, which represents 7.92% of the company's audited net assets as of December 31, 2024 [3][24]. Group 1: Mutual Guarantee Details - The mutual guarantee will be executed with a joint liability guarantee method, and the specific guarantee amount will be based on bank verification [2][16]. - The company has already provided responsibility guarantees for Bozhong Zhizhi and its subsidiary, with Bozhong Zhizhi providing counter-guarantees [2][16]. - The expected guarantee amount is contingent upon the business development and funding needs of Bozhong Zhizhi and its subsidiary [3][19]. Group 2: Approval Process - The proposal for the mutual guarantee was approved in the meetings of the board of directors and the supervisory board held on April 22, 2025 [7][8]. - The proposal will be submitted for approval at the 2024 annual shareholders' meeting, with Bozhong Zhizhi waiving its voting rights on this matter [8][20]. - The guarantee will be effective from the date of approval at the shareholders' meeting until the next annual shareholders' meeting [8][17]. Group 3: Financial Context - As of the announcement date, the company has a total external guarantee balance of approximately 2.37 billion RMB, which is 69.37% of its audited net assets [24]. - The company has no overdue guarantees or guarantees involved in litigation as of the announcement date [25].

前总经理王正民隐瞒关联公司。 用预测收入对投资的前董事长名下公司估值，却被会计所认为依据不足；原总经理的关联公司，隐瞒真 实身份向上市公司采购商品，也因毛利异常，而被会计所质疑。一场年报审计，掀开了ST凯利 （300326.SZ）的多项关联交易背后，可能存在的种种问题。 因关联公司估值依据不足，隐瞒关联方，ST凯利的2024财报被出具保留意见，内控被出具无法表示意 见的审计报告，股票也被实施其他风险警示。 接近ST凯利董监高的知情人士张坤告诉第一财经，估值依据不足的被投企业主要是前董事长袁征的关 联公司，在聘请评估机构过程并未经过监事会或董事会决议，最初评估方法也未获会计所认可；后者则 是前总经理王正民隐瞒个人关联公司，这家公司与ST凯利已有多年交易，其中2022年度交易额和毛利 率明显异常，导致会计所质疑是否存在利益输送或损害上市公司利益的情况。 会计师事务所形成初步审计意见后，还发生了投诉一事。据张坤透露，针对会计所的投诉函并非公司行 为，是个别高管的私下行为，时任董事会成员和高管并不知情，会计所也根据投诉要点进行了一一反 驳。 在监事私下聘用评估机构、袁征的关联公司估值依据不足、王正民隐瞒关联方、个别高 ...

最近三年，威高血净归属于公司普通股股东的净利润分别为3.15亿元、4.42亿元和4.49亿元；营业收入 分别为34.26亿元、35.32亿元和36.04亿元，逐年增长。2022年6月27日，威高血净曾向港交所递交招股 书，但赴港上市最终泡汤。2023年12月30日，威高血净上证主板上市IPO获受理，今年2月26日顺利过 会，3月21日注册生效。 威高血净5月7日发布公告提醒，本次发行价格26.5元/股，发行市盈率为24.82倍，低于中证指数发布的 威高血净所处行业最近一个月平均静态市盈率（28.04倍），低于同行业可比公司静态市盈率平均水 平，存在未来公司股价下跌给投资者带来损失的风险。 对于此次发行上市的目的，威高骨科在招股意向书中表示，是为了提升品牌影响力，增加融资渠道，优 化财务结构；还可以有效提升人才吸引力，强化与行业内国际巨头及国内公众公司的人才竞争优势，并 以股权方式长期激励优秀员工，与投资者共享发展成果。 威高血净上市在即，将成为"威高系"第四家上市公司。5月8日，血透龙头企业山东威高血液净化制品股 份有限公司（股票简称：威高血净，股票代码：603014）开启申购，发行价26.5元/股。本次发行 ...